Download
s11239-020-02202-8.pdf 765,67KB
WeightNameValue
1000 Titel
  • Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19
1000 Autor/in
  1. Rieder , Marina |
  2. Goller, Isabella |
  3. Jeserich, Maren |
  4. Baldus, Niklas |
  5. Pollmeier, Luisa |
  6. Wirth, Luisa |
  7. Supady, Alexander |
  8. Bode, Christoph |
  9. Busch, Hans-Jörg |
  10. Schmid, Bonaventura |
  11. Duerschmied, Daniel |
  12. Gauchel, Nadine |
  13. Lother, Achim |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-07-02
1000 Erschienen in
1000 Quellenangabe
  • 50(3):558-566
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11239-020-02202-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331913/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Abstract COVID-19 is associated with a variety of clinical complications including coagulopathy, which frequently results in venous thromboembolism (VTE). Retrospective analyses reported a markedly increased rate of VTEs in COVID-19. However, most recent studies on coagulopathy in COVID-19 were only focused on critically ill patients, and without suitable control groups. We aimed to evaluate the rate of VTEs in an all-comers cohort with suspected COVID-19 during a 30-days follow-up period. We also studied the level of D-dimers and their association with the course of disease. In our prospective single-center study (DRKS00021206, 03/30/2020), we analyzed 190 patients with suspected COVID-19 admitted to the emergency department between March and April 2020. Forty-nine patients were SARS-CoV-2 positive (25.8%). The 141 SARS-CoV-2-negative patients served as control group. After completion of a 30-days follow-up, VTE was diagnosed in 3 patients of the SARS-CoV-2-positive group (6.1%, amongst these 2 ICU cases) versus 5 patients in the SARS-CoV-2-negative group (3.5%), however the difference was not statistically significant (p = 0.427). 30-days mortality was similar in both groups (6.1% vs. 5%, p = 0.720). Disease severity correlated with the maximum level of D-dimers during follow-up in COVID-19. The rate of VTE was numerically higher in SARS-CoV-2 positive all-comers presenting with suspected COVID-19 as compared to well-matched controls suffering from similar symptoms. VTEs in the COVID-19 group predominantly occurred in ICU courses. The maximum level of D-dimers during follow-up was associated with disease severity in COVID-19, whereas the level of D-dimers at admission was not.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Risk Assessment [MeSH]
lokal Coronavirus Infections/blood [MeSH]
lokal Risk Factors [MeSH]
lokal Host-Pathogen Interactions [MeSH]
lokal D-dimers
lokal Germany/epidemiology [MeSH]
lokal Pneumonia, Viral/blood [MeSH]
lokal Venous Thrombosis/epidemiology [MeSH]
lokal Venous thromboembolism
lokal Male [MeSH]
lokal Pneumonia, Viral/virology [MeSH]
lokal Venous Thrombosis/blood [MeSH]
lokal COVID-19 [MeSH]
lokal Case-Control Studies [MeSH]
lokal Pulmonary Embolism/blood [MeSH]
lokal Venous Thromboembolism/epidemiology [MeSH]
lokal Venous Thromboembolism/diagnosis [MeSH]
lokal SARS-CoV-2 [MeSH]
lokal SARS-CoV-2
lokal Betacoronavirus/pathogenicity [MeSH]
lokal Pulmonary Embolism/virology [MeSH]
lokal Female [MeSH]
lokal Venous Thrombosis/diagnosis [MeSH]
lokal Coronavirus Infections/diagnosis [MeSH]
lokal Adult [MeSH]
lokal Biomarkers/blood [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Severity of Illness Index [MeSH]
lokal Middle Aged [MeSH]
lokal COVID-19
lokal Coronavirus Infections/epidemiology [MeSH]
lokal Pulmonary Embolism/diagnosis [MeSH]
lokal Time Factors [MeSH]
lokal Venous Thromboembolism/blood [MeSH]
lokal Pandemics [MeSH]
lokal Coronavirus Infections/virology [MeSH]
lokal Venous Thromboembolism/virology [MeSH]
lokal Article
lokal Fibrin Fibrinogen Degradation Products/metabolism [MeSH]
lokal Pneumonia, Viral/diagnosis [MeSH]
lokal Pulmonary Embolism/epidemiology [MeSH]
lokal Pneumonia, Viral/epidemiology [MeSH]
lokal Registries [MeSH]
lokal Venous Thrombosis/virology [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-3388-4119|https://frl.publisso.de/adhoc/uri/R29sbGVyLCBJc2FiZWxsYQ==|https://frl.publisso.de/adhoc/uri/SmVzZXJpY2gsIE1hcmVu|https://frl.publisso.de/adhoc/uri/QmFsZHVzLCBOaWtsYXM=|https://frl.publisso.de/adhoc/uri/UG9sbG1laWVyLCBMdWlzYQ==|https://frl.publisso.de/adhoc/uri/V2lydGgsIEx1aXNh|https://frl.publisso.de/adhoc/uri/U3VwYWR5LCBBbGV4YW5kZXI=|https://frl.publisso.de/adhoc/uri/Qm9kZSwgQ2hyaXN0b3Bo|https://frl.publisso.de/adhoc/uri/QnVzY2gsIEhhbnMtSsO2cmc=|https://frl.publisso.de/adhoc/uri/U2NobWlkLCBCb25hdmVudHVyYQ==|https://frl.publisso.de/adhoc/uri/RHVlcnNjaG1pZWQsIERhbmllbA==|https://frl.publisso.de/adhoc/uri/R2F1Y2hlbCwgTmFkaW5l|https://frl.publisso.de/adhoc/uri/TG90aGVyLCBBY2hpbQ==
1000 Hinweis
  • DeepGreen-ID: ea3a91b5619c4b119a1c90c0a656daa2 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6468612.rdf
1000 Erstellt am 2023-11-17T17:26:14.171+0100
1000 Erstellt von 322
1000 beschreibt frl:6468612
1000 Zuletzt bearbeitet 2023-12-01T08:11:10.915+0100
1000 Objekt bearb. Fri Dec 01 08:11:10 CET 2023
1000 Vgl. frl:6468612
1000 Oai Id
  1. oai:frl.publisso.de:frl:6468612 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source